Highlighting NPA’s work on conflicts of interest and commitment to reduce the influence of pharmaceutical marketing on the medical profession
- “Responding to parts 2-3 of New England Journal of Medicine’s series on pharma-MD relations,” HealthNewsReview.org (5/21/2015)
- “Criticism of NEJM’s defense of industry-physician relations,” HealthNewsReview.org (5/14/2015)
- “Nothing’s free, in Saturday letters: A light on drugs, doctors,” Houston Chronicle, (8/2/2014) responding to “Federal website to shine light on drug companies, doctors Patients will be able to track manufacturers’ ties to providers,” published 7/27/2014
- “How Pharma Got Doctors to Prescribe Risperdal, Wellbutrin, Bextra, Neurontin, Prempro and More,” OEN OpEdNews.com (2/17/2014)
- “Should Doctors Be Barred From Accepting Perks?” Kiplinger (11/2013)
- “The Influence of Ownership on Human Behavior: ‘Feeding the Beast’” The Medical Professionalism Blog (11/20/2013)
- “Setting Boundaries: ‘Unbranded Doctor’ Campaign Helps Clarify Potential Conflicts” LeadDoc (10/24/2013)
- “CarePoint Health Medical Group Physicians: Networking for Better Outcomes and Efficient Practices,” MD News (5/30/2013)
- “Practicing medicine pharma-free in a drug rep-filled world,” UW Medicine Magazine, former Past-President David Evans interviewed (5/22/2013)
- “The Independent Payment Advisory Board and Medicare Spending: New Research Suggests a Change in Our Medical Culture,” Health Beat (5/7/2013)
- “Consider the source – How academic detailing improves patient care,” Medical College of Wisconsin Alumni Magazine (Spring 2013)
- “Roche promises greater access to clinical trial data,” PMLiVE (2/27/2013)
- “Know which pharmaceutical companies are paying your doctor,” Seattle Times (2/16/2013)
- “What the Sunshine Act Means for Health Care Transparency,” The Atlantic (2/5/2013)
- “Health Care’s Trick Coin,” New York Times (2/1/2013)
- “Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis,” BMJ, NPA member Joseph Ross co-author (1/31/2013)
- “Lobbyists air concerns about doctor gift-disclosure rule at White House,”RegWatch, The Hill’s Regulation Blog (1/29/2013)
- “Clamor for Sunshine Act Rules Continues,” MedPage Today (1/16/2013)
- “AARP, AFL-CIO urge OMB to issue Sunshine Act rules,” The Hill Healthwatch Blog (1/15/2013)
- “The National Physicians Alliance and the American Medical Student Association request full implementation of the sunshine act,” Lexology (1/9/2013)
- “Groups Urge HHS To Issue Rule on Doctor Payment Disclosure,” iHealthBeat (1/8/2013)
- “Providers still waiting on Sunshine Act implementation,” FierceHealthCare (1/8/2013)
- “Groups Urge HHS To Issue Rules On Medical Company-Doc Relationships,” Kaiser Health News (1/7/2013)
- “Where’s the Physician Sunshine Rule Already?” Politico (1/4/2013)
- “Groups to HHS: Issue Sunshine Act Rules,” MedPage Today (1/4/2013)
- “For Bay State ‘modest meals’ are in the eye of the beholder,” Medical Marketing and Media (10/25/2012)
- “State House News – Patrick mulls gift ban law changes,” State House News Service (7/6/2012)
- “Disclosure can address doctors’ conflicts of interest,” Philadelphia Inquirer, op-ed by NPA member and director of Pew Prescription Project Daniel Carlat (6/26/2012)
- “Industry and Academic Medicine: What Does the Future Hold?” UConn Today Blog (6/22/2012)
- “Dr. Valerie Arkoosh, President of the National Physicians Alliance,” Conversations on Health Care (6/13/2012)
- “Casting more light on doctors’ financial ties may be delayed,” News Works, NPA member Daniel Carlat quoted (6/1/2012)
- “Conflicts of Interest in Health Care,” Where We Live, NPA member Stephen Smith interviewed (5/2/2012)
- “Physicians With Conflicts of Interest,” Health Affairs (4/20120)
- “Consumers Digest Discovers Pharma Influence over Medicine,” Hooked: Ethics, Medicine, and Pharma (3/23/2012)
- “Under the Influence: How Doctors are Courted by Drugmakers,” Consumer Digest (March/April 2012)
- “It’s Enough to Make You Sick,” Consumer Digest (March/April 2012)
- “What Will End the Era of the Blockbuster Drug?” Time (12/13/2011)
- “The End of Blockbuster Drugs?” The New Health Dialogue (12/13/2011)
- “Bipartisan Bill Would Relax FDA Conflicts-of-Interest Policies,” RegBlog (10/20/2011)
- “Financial Conflicts ‘Pervasive’ On Key Medical Panels,” NPR’s Health Blog (10/12/2011)
- “Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study,” British Medical Journal (10/11/2011)
- “Choosing brand-name over generic statins can cost billions,” heartwire (10/3/2011)
- “Consumer Reports publication quite useful,” Madras Pioneer (9/07/2011)
- “National Physicians Group Protests FDA Attempts to Allow Industry Influence,” POGO (8/11/2011)
- “Watchdogs bark as FDA relaxes rules on conflict of interest,” MM&M (8/9/2011)
- “One practice’s experiment in refusing detail rep visits,” Journal of Family Practice (8/2011)
- “Data-mining law struck down: Supreme Court sides with drug companies in Vermont ruling,” Modern Healthcare (6/27/2011)
- “How to Look Good Naked,” Blue Latitude (6/17/2011)
- “Implementation of the Physician Sunshine Payment Provision: CMS gearing-up to publish notice of proposed rulemaking,” Premier Surgeon (6/13/2011)
- “When to just say no,” Center for Medical Consumers (6/10/2011)
- “Doctors Dos and Don’ts,” One Medical Group Blog (6/10/2011)
- “Under the Influence: Doctors getting big bucks from Big Pharma,” KVNO News (6/2/2011)
- “Under the Influence – Omaha doctors receive big money from big pharma,” The Reader (6/1/2011)
- “Why Don’t You Profit When Pharmacies Sell Your Prescription?” Huffington Post (5/20/2011)
- Cross-posted at Guernica
- “Limitations Of The Evidence Base For Prescribing Aripiprazole In Maintenance Therapy Of Bipolar Disorder,” Medical News Today (5/3/2011)
- “Inverse benefits due to drug marketing undermine patient safety and public health,” EurekAlert! (1/13/2011)
- Reposted at ScienceBlog
- “The Unbranded Doctor,” Jack’s posterous (1/13/2011)
- Reposted at PharmaGossip
- Reposted at Mark Walmsley Blog
- “New database shows how much drug companies pay doctors,” Philadelphia Inquirer (10/28/2010)
- “Drug Companies Hire Troubled Doctors As Experts,” NPR (10/19/2010)
- “Consumer Reports: Most Patients Worry About Pharma Payments to Doctors,” ProPublica (10/18/2010)
- “Drugmakers hold too much influence over doctors’ decisions, public says,” American Medical News (9/13/2010)
- “Harvard Medical School Restricts Faculty Ties to Industry,” The Harvard Crimson (7/21/2010)
- “Avandia Debated LIVE,” AlexO’Meara.com (7/14/2010)
- “F.D.A. Panel Votes to Restrict Avandia,” New York Times Health Blog (7/14/2010)
- “N.Y., Minnesota consider new rules on pharma gifts” American Medical News (2/12/2010)
- “Legislators move to tighten rules for drug companies,” KARE 11, NBC affiliate Minneapolis – St. Paul (1/26/2010)
- “Groups want tighter controls over drug industry influence,” Minnesota Public Radio (1/26/2010)
- “Common-sense Rx reforms in Minnesota important to seniors, consumers,” Postscript Blog (1/25/2010)
- “Lawmakers debate prescription drug reforms,” Session Daily (1/25/2010)
- “Ethicists Prod NIH to Spend Money Investigating Conflicts of Interest,”The Chronicle of Higher Education (11/17/2009)
- “UVa posting its doctors’ financial deals online,” Charlottesville Daily Progress (11/12/2009)
- “An Even Better Picture of Most Influential Doctors in US,” USA Today (10/14/2009)
- “Service helps health care providers prescribe drugs,” Bangor Daily News (9/21/2009)
- “A Fierce Fight Over Free Lunches for Physicians,” Hartford Courant (5/25/2009)
- “Bill Would Limit ‘Gifts’ to Doctors,” ConnPost.Com (4/28/2009)
- “Doctors increasingly close doors to drug reps,…” American Medical News (3/23/2009)
- “Attorney General: ban gifts to doctors from drug reps,” Hartford Courant (3/9/2009)
- “Will biotech change pharma ethics?” ZDNet Healthcare (9/11/08)
- “Sale of Information to Drug Makers Questioned,” Times-West Virginia (7/30/08)
- “Lawmakers hear debate on doctor data mining,” Charleston Gazette (7/30/08)
- “Curbs eyed for Sales of W.VA. Info to Drug Makers,” CNNMoney.com (7/29/08)
- “Gift Ban Bill Gains Backers,” Boston Globe (6/24/08)
- “Bill Aims to Cure Costly Side Effects of Doctor Gifts,” Public News Service (5/28/08)
- “Bill Would Let Pharmacies Sell Medical Records,” San Francisco Chronicle (5/28/08)
- Letter to Editor re: ghostwriting and gifts to physicians, Baltimore Sun (4/25/08)
- Letter to Editor re: Gifts to Physicians, New York Times, (4/22/08)
- Letter to Editor re: MA Senate Gift Ban proposal, Boston Herald, (4/21/08)
- “Rx ‘Data Mining’ Legislation Awaits Action in CA, Dies in WA State,” Drug Benefit News (4/04/08)
- “Physician Gifting Crackdown,” Pharmaceutical Executive (3/26/08)
- “Bill Makes it Illegal for Drug Makers to buy Prescription Data for Marketing,” Tacoma News Tribune (2/26/08)
- “Datamining Should get the Shaft,” Seattle Times (2/26/08)
- “Gathering Data on Docs,” PhillyBurbs.com (1/20/08)
- “Doctor Combats Pull of Drug Reps” St. Petersburg Times (12/27/07)
- “Dr. Drug Rep,” NYT Magazine (11/25/07)
- “Groups Back Physician Gift Disclosure Measure,” Congressional Quarterly HealthBeat (10/23/07)
- “Putting a Stop to Pharmaceutical Datamining,” op-ed in Lewiston (Maine) Sun Journal (9/30/07)
- “Improving Health Care or Invading Privacy?” Fosters.com & Laconia (NH) Citizen (9/30/07)
- “States Move to Close Drug Data Mining,” NPR Marketplace (10/2/07)
- “Physicians Should Opt-Out,” Bangor Daily News (9/13/07)
- ReachMD, XM Satellite Radio
- “Opinion Piece Criticizes Sale of Physician Prescribing Data,” Kaiser Family Foundation (7/26/07)
- “Drug Industry Mines Physicians’ Data to Boost Sales,” NPR Morning Edition (6/26/07)
- “Prescription Mining Raises Millions for Doctors’ Group,” San Francisco Chronicle (7/25/07)
- “AMA Faces Storm on Data Sales,” Chicago Tribune (6/24/07)
- “Law Targets Drug Marketing Practices” Hudson Valley Business News (6/12/07)
- “Controversy erupts over pharmaceutical marketing policies,” Dental Tribune
- FDA Week- coverage regarding New Hampshire ruling on prescription data mining
- “Doctors, Lawmakers Resist Drugmakers’ Prying Eyes,” Washington Post (5/22/07) A01
- Editorial voicing the NPA’s support of a bill before the Maine legislature: LD 838, An Act Protecting the Confidentiality of Prescription Information (4/13/07, Kennebec Journal)
- “As drug companies push their pills over TV, some are asking: Is that good for your health?” Columbia News Service (4/1/08)
- Maine Public Radio (3/27/07) interview with NPA Campaign leader Ben Schaefer on the NPA’s support of a prescription privacy bill pending in the Maine legislature
- “Prescription for Conflict” (3/17/07, Journal News)
- “No Free Lunch,” Pitt Medicine profile of NPA board member Dave Evans whose practice refuses gifts, visits, and samples from pharmaceutical detailers
Barbara Meier schreibt seit vielen Jahren für die NPAlliance Ratgeber und Testberichte. Dabei legt sie großen Wert auf die Ausführlichkeit sowie Richtigkeit ihrer Artikel. Sie zählt zu den wenigen Experten in ihrem Gebiet und hat sich über die letzten Jahren einen Namen in der Gesundheitsbranche gemacht.